General Dermatology

“This approval reflects our dedication to ensuring high-quality treatments are universally accessible,” Claire D’Abreu-Hayling, chief scientific officer of Sandoz, said in a news release.

Since the first electronic medical record emerged in 1972, clinicians have found themselves increasingly trapped behind screens.

Despite high accuracy scores, the study found AI models often produce overly complex explanations, making them less effective for patient education.

Myron Czuczman, MD, of Citius Pharmaceuticals recently shared perspectives on the role and potential of Lymphir in CTCL.

A recent Australian study reviewed appropriate terminology, gender affirming options, and dermatological considerations in caring for gender-diverse patients.

Researchers emphasized the need for improved reliability and regulatory frameworks for AI tools before they are integrated into dermatological practice.

The approval is supported by positive phase 3 data for Lymphir in this indication.

Young patients are heading back to school, and common skin issues like acne, eczema, warts, and pigmentation can affect their confidence, Shanna Miranti, MPAS, PA-C, writes.

Topical corticosteroids are the gold standard treatment for VLS, yet women with skin of color are not represented in studies.

Our August issue covers common back-to-school skin conditions, psoriasis research, OX40 inhibition for atopic dermatitis, and pediatric dermatology meeting highlights.

A group of international experts focused on the technology’s potential to standardize and enhance patient assessments.

The 15-piece questionnaire is designed to be quick and easy to use during consultations, with particular benefits across numerous specialties.

Researchers stated the drug could avoid the need for additional immunosuppressive treatments associated with increased morbidity and mortality.

PIH, more prominent in darker skin types, often leads to significant psychosocial distress and reduced quality of life.

Dermatology Times is looking back on the top stories in dermatology from the month of July.

Dermatology Times is recapping our top expert interviews from the month of July.

A recent review called for gender-specific studies to enhance dermatological treatments and potentially revise guidelines.

Generation Z patients had lower atopic dermatitis severity but similar disease perception compared to Millennial patients.

Take a deep dive into the 3 approvals for various dermatological conditions this month.

Researchers reported gender differences among individuals with skin conditions and compared sociodemographic, clinical and psychological variables.

Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.

Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation.

A recent study examined skin manifestations and SS from a dermatological perspective.

Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.

A recent review investigated all known information between skin conditions and sleep disorders, finding a bidirectional influence between them.

Keep up with the latest headlines in dermatology from the past week, including racial disparities in hidradenitis suppurativa, Stanford Medicine's new Skin of Color program, and more.

In case you missed it, this week we had news about Oleogel-10's potential in dressing changes for pediatric patients with epidermolysis bullosa, data for repigmentation with ruxolitinib cream, a review of pediatric cutaneous Crohn disease, and more.

The study saw a reduction of 2 major UVA-induced mtDNA deletions associated with skin photoaging.

A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.

TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.